In HCC and prostate cancer, ketogenesis-related hydroxy-methyl-glutaryl-CoA synthase 2 (HMGCS2) inhibits tumor proliferation and metastasis [11–13], whereas exogenous ketone bodies also show the similar effects in pancreatic cancer [14, 15]. The gene discussed is HMGCS2; the disease is neoplasm.